Latest news
PepGen - Cash of $117.20 Mln as of June 30, 2 - MoomooMoomoo · Fri, 07 Aug 2026 11:40:30 GMTCraig-Hallum Maintains PepGen(PEPG.US) With Buy Rating, Maintains Target Price $11 - MoomooMoomoo · Fri, 07 Aug 2026 03:30:46 GMTPepgen Inc. (PGN) 2026 Q2 10-Q Report: Financials, Risks, and Forward-Looking Statements Overview - MinichartMinichart · Thu, 06 Aug 2026 23:51:00 GMTPepGen Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 13:58:30 GMTPepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review - BioSpaceBioSpace · Thu, 06 Aug 2026 12:39:14 GMTPepGen advances PGN-EDODM1 into 12.5 mg/kg cohort in Phase 2 FREEDOM2-DM1 trial - BitgetBitget · Thu, 06 Aug 2026 12:22:19 GMTPepGen Q2 2026 earnings: Lower R&D spending narrows the net loss - TradingKeyTradingKey · Thu, 06 Aug 2026 12:12:51 GMTPepGen Inc. 1H 2026: Net loss $(35.6M), EPS $(0.51) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 11:41:01 GMT